MOKARI ATABAK (Chief Financial Officer) sold 71.3% of their position (40K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $3.25M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+40K
Price / share
$19.26
Trade value
$770.40K
% of position
Common Stock
Shares
−9.43K
Price / share
$80.02
Trade value
$754.92K
% of position
Common Stock
Shares
−11.08K
Price / share
$80.94
Trade value
$896.92K
% of position
Common Stock
Shares
−19.48K
Price / share
$81.81
Trade value
$1.59M
% of position
Common Stock
Shares
−2.00
Price / share
$82.45
Trade value
$164.90
% of position
Net shares
+0.00
Net value
-$2.48M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | M · Option Exercise | +40K | $19.26 | $770.40K | 248.0% | 16.13K | 56.13K |
| Common Stock Direct | 6/15/2026 | S · Sale | −9.43K | $80.02 | $754.92K | 16.8% | 56.13K | 46.70K |
| Common Stock Direct | 6/15/2026 | S · Sale | −11.08K | $80.94 | $896.92K | 23.7% | 46.70K | 35.62K |
| Common Stock Direct | 6/15/2026 | S · Sale | −19.48K | $81.81 | $1.59M | 54.7% | 35.62K | 16.13K |
| Common Stock Direct | 6/15/2026 | S · Sale | −2.00 | $82.45 | $164.90 | 0.0% | 16.13K | 16.13K |
| Total | +0.00 | -$2.48M | ||||||
Stock option (right to buy)
Common Stock
40K shares
Shares
−40K
Strike price
19.26
Held after
20K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock40K shares | 6/15/2026 | M · Option Exercise | −40K | 19.26 | — | 20K |